Marie Elizabeth McDonnell, M.D.
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
Name | Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
---|
Diabetes Mellitus | 32 | 2024 | 5755 | 3.400 |
Why?
|
Hyperglycemia | 14 | 2024 | 1372 | 2.820 |
Why?
|
Hypoglycemic Agents | 15 | 2024 | 2875 | 1.170 |
Why?
|
Diabetes Mellitus, Type 1 | 6 | 2024 | 3336 | 1.000 |
Why?
|
Blood Glucose | 17 | 2024 | 6259 | 0.850 |
Why?
|
Diabetic Ketoacidosis | 2 | 2020 | 247 | 0.820 |
Why?
|
Insulin | 13 | 2022 | 6583 | 0.790 |
Why?
|
Diabetic Cardiomyopathies | 2 | 2018 | 96 | 0.710 |
Why?
|
Diabetes Mellitus, Type 2 | 16 | 2023 | 11732 | 0.670 |
Why?
|
Beverages | 2 | 2019 | 821 | 0.570 |
Why?
|
Diabetic Angiopathies | 2 | 2018 | 820 | 0.530 |
Why?
|
Diabetic Neuropathies | 2 | 2019 | 410 | 0.510 |
Why?
|
Long-Term Care | 1 | 2018 | 607 | 0.490 |
Why?
|
Toll-Like Receptors | 4 | 2010 | 592 | 0.490 |
Why?
|
Dietary Carbohydrates | 1 | 2019 | 906 | 0.470 |
Why?
|
Access to Information | 1 | 2016 | 320 | 0.450 |
Why?
|
Cost Sharing | 2 | 2015 | 407 | 0.440 |
Why?
|
B-Lymphocytes | 6 | 2015 | 4665 | 0.440 |
Why?
|
Diabetes Complications | 2 | 2019 | 1361 | 0.430 |
Why?
|
Perioperative Care | 4 | 2016 | 1000 | 0.420 |
Why?
|
Medicare Part D | 2 | 2015 | 328 | 0.420 |
Why?
|
Patient Participation | 1 | 2021 | 1457 | 0.410 |
Why?
|
Hospitalization | 6 | 2023 | 10262 | 0.390 |
Why?
|
Medication Adherence | 5 | 2021 | 2062 | 0.390 |
Why?
|
Omentum | 1 | 2012 | 170 | 0.390 |
Why?
|
Preoperative Care | 1 | 2019 | 2246 | 0.350 |
Why?
|
Postoperative Complications | 3 | 2019 | 15294 | 0.340 |
Why?
|
Blood Glucose Self-Monitoring | 5 | 2024 | 434 | 0.330 |
Why?
|
Patient Education as Topic | 2 | 2016 | 2277 | 0.330 |
Why?
|
Telemedicine | 4 | 2022 | 2872 | 0.320 |
Why?
|
Subcutaneous Fat | 1 | 2012 | 391 | 0.320 |
Why?
|
Hypoglycemia | 2 | 2016 | 861 | 0.320 |
Why?
|
Coronavirus Infections | 3 | 2020 | 3132 | 0.310 |
Why?
|
Emergency Service, Hospital | 2 | 2018 | 7659 | 0.310 |
Why?
|
Pneumonia, Viral | 3 | 2020 | 3239 | 0.310 |
Why?
|
Obesity | 11 | 2023 | 12742 | 0.310 |
Why?
|
Breast Neoplasms | 3 | 2024 | 20817 | 0.290 |
Why?
|
Humans | 81 | 2024 | 744220 | 0.290 |
Why?
|
Antithyroid Agents | 1 | 2006 | 70 | 0.280 |
Why?
|
Endocrinology | 4 | 2022 | 443 | 0.280 |
Why?
|
Ethionamide | 1 | 2005 | 11 | 0.270 |
Why?
|
Insulin Resistance | 6 | 2023 | 3863 | 0.260 |
Why?
|
Intraoperative Complications | 1 | 2012 | 1195 | 0.260 |
Why?
|
Practice Guidelines as Topic | 8 | 2022 | 7281 | 0.250 |
Why?
|
Hospital Mortality | 4 | 2024 | 5316 | 0.230 |
Why?
|
Internal Medicine | 1 | 2010 | 1009 | 0.220 |
Why?
|
Atherosclerosis | 2 | 2019 | 3444 | 0.220 |
Why?
|
Cytokines | 6 | 2015 | 7326 | 0.210 |
Why?
|
Coronary Artery Bypass | 1 | 2012 | 2289 | 0.210 |
Why?
|
Evidence-Based Medicine | 4 | 2022 | 3611 | 0.200 |
Why?
|
Prediabetic State | 2 | 2024 | 499 | 0.190 |
Why?
|
Middle Aged | 29 | 2024 | 213367 | 0.190 |
Why?
|
Kidney Transplantation | 1 | 2016 | 4251 | 0.190 |
Why?
|
Body Weight | 1 | 2011 | 4666 | 0.180 |
Why?
|
Exercise Therapy | 1 | 2007 | 906 | 0.180 |
Why?
|
Metformin | 2 | 2014 | 835 | 0.180 |
Why?
|
Hypothyroidism | 1 | 2005 | 659 | 0.180 |
Why?
|
Health Services Accessibility | 2 | 2018 | 5138 | 0.180 |
Why?
|
Cardiac Surgical Procedures | 2 | 2012 | 3533 | 0.180 |
Why?
|
Pregnancy in Diabetics | 1 | 2021 | 179 | 0.170 |
Why?
|
Neoplasms | 4 | 2021 | 21672 | 0.170 |
Why?
|
Personal Satisfaction | 1 | 2024 | 643 | 0.170 |
Why?
|
Thyroid Nodule | 1 | 2006 | 750 | 0.170 |
Why?
|
Female | 37 | 2024 | 380197 | 0.170 |
Why?
|
Quality Improvement | 2 | 2018 | 3746 | 0.160 |
Why?
|
Colitis, Ulcerative | 1 | 2010 | 1912 | 0.160 |
Why?
|
Venous Thrombosis | 1 | 2007 | 1238 | 0.160 |
Why?
|
Education, Medical, Graduate | 1 | 2010 | 2291 | 0.150 |
Why?
|
Hypogonadism | 1 | 2024 | 798 | 0.150 |
Why?
|
Crohn Disease | 1 | 2010 | 2303 | 0.150 |
Why?
|
Carbohydrates | 1 | 2019 | 393 | 0.150 |
Why?
|
Antitubercular Agents | 1 | 2005 | 1320 | 0.150 |
Why?
|
Tuberculosis, Multidrug-Resistant | 1 | 2005 | 912 | 0.150 |
Why?
|
Curriculum | 1 | 2010 | 3604 | 0.140 |
Why?
|
Diagnostic Techniques, Endocrine | 1 | 2016 | 45 | 0.140 |
Why?
|
Aged | 21 | 2023 | 163253 | 0.140 |
Why?
|
Adult | 28 | 2022 | 214035 | 0.140 |
Why?
|
Vasodilation | 3 | 2010 | 944 | 0.140 |
Why?
|
Retrospective Studies | 12 | 2023 | 77426 | 0.130 |
Why?
|
Inpatients | 5 | 2020 | 2518 | 0.130 |
Why?
|
Risk Assessment | 2 | 2016 | 23337 | 0.130 |
Why?
|
Cardiovascular Diseases | 3 | 2017 | 15161 | 0.130 |
Why?
|
Male | 29 | 2024 | 350027 | 0.130 |
Why?
|
Biometry | 1 | 2018 | 558 | 0.130 |
Why?
|
Receptor, erbB-2 | 2 | 2022 | 2416 | 0.130 |
Why?
|
Administration, Oral | 3 | 2015 | 3913 | 0.130 |
Why?
|
Prescription Drugs | 1 | 2021 | 595 | 0.120 |
Why?
|
Thiazoles | 1 | 2022 | 1484 | 0.120 |
Why?
|
Glucose | 2 | 2024 | 4396 | 0.120 |
Why?
|
Pandemics | 4 | 2021 | 8387 | 0.120 |
Why?
|
Receptors, Estrogen | 1 | 2022 | 2186 | 0.120 |
Why?
|
Disease Management | 2 | 2021 | 2458 | 0.110 |
Why?
|
Patient Discharge | 2 | 2018 | 3313 | 0.110 |
Why?
|
Self Care | 1 | 2018 | 786 | 0.110 |
Why?
|
Aged, 80 and over | 8 | 2023 | 57768 | 0.110 |
Why?
|
Hyperparathyroidism, Secondary | 1 | 2013 | 126 | 0.110 |
Why?
|
Infusions, Parenteral | 1 | 2012 | 415 | 0.110 |
Why?
|
Glucocorticoids | 1 | 2021 | 2108 | 0.100 |
Why?
|
Orthopedic Procedures | 1 | 2022 | 1288 | 0.100 |
Why?
|
Ambulatory Care | 3 | 2022 | 2708 | 0.100 |
Why?
|
Dyspnea | 1 | 2000 | 1303 | 0.100 |
Why?
|
General Practice | 1 | 2012 | 100 | 0.100 |
Why?
|
Insulin Infusion Systems | 1 | 2013 | 212 | 0.100 |
Why?
|
Patient-Centered Care | 1 | 2021 | 1438 | 0.100 |
Why?
|
Diabetes, Gestational | 1 | 2021 | 1184 | 0.100 |
Why?
|
Body Mass Index | 4 | 2012 | 12718 | 0.100 |
Why?
|
Cushing Syndrome | 1 | 2012 | 249 | 0.100 |
Why?
|
Brachial Artery | 3 | 2010 | 370 | 0.090 |
Why?
|
Communication | 2 | 2021 | 3749 | 0.090 |
Why?
|
Academic Medical Centers | 2 | 2018 | 2759 | 0.090 |
Why?
|
Delivery of Health Care | 2 | 2018 | 5319 | 0.090 |
Why?
|
Postoperative Care | 2 | 2016 | 1485 | 0.090 |
Why?
|
Endothelium, Vascular | 4 | 2010 | 4455 | 0.090 |
Why?
|
Receptor Cross-Talk | 1 | 2009 | 119 | 0.090 |
Why?
|
Antigens, CD19 | 1 | 2012 | 380 | 0.090 |
Why?
|
HMGB1 Protein | 1 | 2010 | 133 | 0.080 |
Why?
|
Th17 Cells | 1 | 2015 | 766 | 0.080 |
Why?
|
Chronic Periodontitis | 1 | 2009 | 101 | 0.080 |
Why?
|
Referral and Consultation | 2 | 2018 | 3528 | 0.080 |
Why?
|
Recovery of Function | 1 | 2019 | 2925 | 0.080 |
Why?
|
Saliva | 1 | 2012 | 809 | 0.080 |
Why?
|
Prognosis | 5 | 2022 | 29050 | 0.080 |
Why?
|
Stress, Physiological | 1 | 2016 | 1404 | 0.080 |
Why?
|
Panniculitis | 1 | 2008 | 44 | 0.080 |
Why?
|
Tumor Necrosis Factor-alpha | 3 | 2015 | 4419 | 0.080 |
Why?
|
Lupus Nephritis | 1 | 2011 | 310 | 0.080 |
Why?
|
Drug Costs | 1 | 2015 | 1105 | 0.080 |
Why?
|
Life Style | 1 | 2019 | 3835 | 0.070 |
Why?
|
Tibia | 1 | 2013 | 1077 | 0.070 |
Why?
|
Creatinine | 1 | 2012 | 1919 | 0.070 |
Why?
|
Nitric Oxide Synthase | 1 | 2009 | 916 | 0.070 |
Why?
|
Abdominal Fat | 1 | 2008 | 223 | 0.070 |
Why?
|
Saphenous Vein | 1 | 2009 | 532 | 0.070 |
Why?
|
Case-Control Studies | 2 | 2016 | 21752 | 0.070 |
Why?
|
Chi-Square Distribution | 1 | 2012 | 3509 | 0.070 |
Why?
|
Benchmarking | 1 | 2012 | 1042 | 0.070 |
Why?
|
Treatment Outcome | 6 | 2019 | 63119 | 0.070 |
Why?
|
Cost-Benefit Analysis | 1 | 2018 | 5396 | 0.070 |
Why?
|
Patient Readmission | 2 | 2017 | 3114 | 0.070 |
Why?
|
Adipose Tissue | 2 | 2008 | 3278 | 0.070 |
Why?
|
Lipopolysaccharides | 2 | 2010 | 2216 | 0.070 |
Why?
|
Monocytes | 2 | 2015 | 2594 | 0.070 |
Why?
|
Flow Cytometry | 3 | 2010 | 5974 | 0.070 |
Why?
|
Myocardial Revascularization | 1 | 2009 | 841 | 0.070 |
Why?
|
Logistic Models | 3 | 2017 | 13409 | 0.060 |
Why?
|
Liver Function Tests | 1 | 2006 | 528 | 0.060 |
Why?
|
Hydrocortisone | 1 | 2012 | 1826 | 0.060 |
Why?
|
Anesthesia | 1 | 2016 | 1548 | 0.060 |
Why?
|
Health Personnel | 1 | 2018 | 3216 | 0.060 |
Why?
|
Choristoma | 1 | 2006 | 213 | 0.060 |
Why?
|
Odds Ratio | 2 | 2015 | 9849 | 0.060 |
Why?
|
Vitamin D Deficiency | 1 | 2013 | 1343 | 0.060 |
Why?
|
Chronic Disease | 1 | 2018 | 9147 | 0.060 |
Why?
|
Tomography, Emission-Computed | 1 | 2006 | 1144 | 0.060 |
Why?
|
Length of Stay | 2 | 2016 | 6308 | 0.060 |
Why?
|
Ligands | 1 | 2010 | 3294 | 0.060 |
Why?
|
Weight Loss | 3 | 2010 | 2622 | 0.060 |
Why?
|
Kidney Failure, Chronic | 1 | 2016 | 2538 | 0.060 |
Why?
|
Health Care Costs | 1 | 2016 | 3209 | 0.060 |
Why?
|
Iodine Radioisotopes | 1 | 2006 | 1032 | 0.050 |
Why?
|
Qualitative Research | 3 | 2021 | 2682 | 0.050 |
Why?
|
Risk Factors | 4 | 2016 | 72280 | 0.050 |
Why?
|
T-Lymphocyte Subsets | 1 | 2010 | 1838 | 0.050 |
Why?
|
Monitoring, Intraoperative | 1 | 2009 | 953 | 0.050 |
Why?
|
Guideline Adherence | 1 | 2012 | 2266 | 0.050 |
Why?
|
Endocrine System | 1 | 2022 | 113 | 0.050 |
Why?
|
Inflammation Mediators | 1 | 2010 | 1889 | 0.050 |
Why?
|
Models, Statistical | 1 | 2016 | 5102 | 0.050 |
Why?
|
Radiography | 1 | 2012 | 7022 | 0.050 |
Why?
|
Antineoplastic Combined Chemotherapy Protocols | 1 | 2022 | 11493 | 0.050 |
Why?
|
Schizophrenia | 1 | 1999 | 6882 | 0.050 |
Why?
|
Immunohistochemistry | 2 | 2012 | 11368 | 0.050 |
Why?
|
Phosphatidylinositol 3-Kinase | 1 | 2021 | 130 | 0.050 |
Why?
|
Phosphatidylinositols | 1 | 2021 | 291 | 0.050 |
Why?
|
Adipocytes | 1 | 2007 | 1182 | 0.050 |
Why?
|
Cohort Studies | 4 | 2023 | 40559 | 0.050 |
Why?
|
Patient Satisfaction | 1 | 2012 | 3395 | 0.050 |
Why?
|
Wounds and Injuries | 1 | 2012 | 2400 | 0.040 |
Why?
|
Prostatic Neoplasms | 1 | 2023 | 11074 | 0.040 |
Why?
|
Vitamin D | 1 | 2013 | 3222 | 0.040 |
Why?
|
Lymphocyte Activation | 1 | 2010 | 5523 | 0.040 |
Why?
|
Critical Care | 1 | 2012 | 2644 | 0.040 |
Why?
|
T-Lymphocytes, Regulatory | 1 | 2013 | 2988 | 0.040 |
Why?
|
NF-kappa B | 1 | 2008 | 2501 | 0.040 |
Why?
|
Critical Illness | 1 | 2012 | 2670 | 0.040 |
Why?
|
Thyroid Gland | 1 | 2006 | 1172 | 0.040 |
Why?
|
Young Adult | 6 | 2017 | 56436 | 0.040 |
Why?
|
Technology | 1 | 2021 | 304 | 0.040 |
Why?
|
Policy | 1 | 2022 | 508 | 0.040 |
Why?
|
Hormone Replacement Therapy | 1 | 2024 | 744 | 0.040 |
Why?
|
Antineoplastic Agents | 1 | 2021 | 13668 | 0.040 |
Why?
|
Cambodia | 1 | 2018 | 191 | 0.040 |
Why?
|
Drug Therapy, Combination | 2 | 2015 | 6485 | 0.040 |
Why?
|
Hospitals | 1 | 2010 | 3952 | 0.030 |
Why?
|
Diagnosis, Differential | 2 | 2011 | 12961 | 0.030 |
Why?
|
Algorithms | 1 | 2016 | 13885 | 0.030 |
Why?
|
Predictive Value of Tests | 1 | 2012 | 15070 | 0.030 |
Why?
|
Androgens | 1 | 2023 | 1279 | 0.030 |
Why?
|
Adolescent | 5 | 2016 | 85759 | 0.030 |
Why?
|
Perioperative Period | 1 | 2016 | 256 | 0.030 |
Why?
|
Antineoplastic Agents, Hormonal | 1 | 2023 | 1509 | 0.030 |
Why?
|
Models, Organizational | 1 | 2018 | 574 | 0.030 |
Why?
|
Morbidity | 1 | 2000 | 1769 | 0.030 |
Why?
|
Androgen Antagonists | 1 | 2023 | 1361 | 0.030 |
Why?
|
Hyperlipidemias | 1 | 2019 | 788 | 0.030 |
Why?
|
Sirolimus | 1 | 2021 | 1563 | 0.030 |
Why?
|
Prospective Studies | 3 | 2023 | 53280 | 0.030 |
Why?
|
Macrophages | 1 | 2008 | 5657 | 0.030 |
Why?
|
False Negative Reactions | 1 | 2014 | 587 | 0.030 |
Why?
|
Testosterone | 1 | 2024 | 2411 | 0.030 |
Why?
|
C-Reactive Protein | 3 | 2010 | 3778 | 0.030 |
Why?
|
Ireland | 1 | 2012 | 161 | 0.030 |
Why?
|
Heart Diseases | 1 | 2006 | 2790 | 0.030 |
Why?
|
Inflammation | 4 | 2015 | 10634 | 0.030 |
Why?
|
Proto-Oncogene Proteins c-akt | 1 | 2021 | 2503 | 0.030 |
Why?
|
Pakistan | 1 | 2013 | 296 | 0.030 |
Why?
|
Mice, Obese | 1 | 2013 | 424 | 0.030 |
Why?
|
TOR Serine-Threonine Kinases | 1 | 2021 | 2108 | 0.030 |
Why?
|
Physician's Role | 1 | 2019 | 942 | 0.030 |
Why?
|
Diabetic Nephropathies | 1 | 2019 | 985 | 0.030 |
Why?
|
Continuity of Patient Care | 1 | 2019 | 1049 | 0.030 |
Why?
|
Placenta | 1 | 2021 | 1697 | 0.030 |
Why?
|
Cells, Cultured | 3 | 2015 | 19227 | 0.030 |
Why?
|
Infusions, Intravenous | 1 | 2016 | 2272 | 0.030 |
Why?
|
Phosphatidylinositol 3-Kinases | 1 | 2021 | 2938 | 0.020 |
Why?
|
General Practitioners | 1 | 2012 | 103 | 0.020 |
Why?
|
Periodicity | 1 | 2012 | 363 | 0.020 |
Why?
|
Accidental Falls | 1 | 2019 | 1062 | 0.020 |
Why?
|
Adaptation, Psychological | 1 | 2021 | 2576 | 0.020 |
Why?
|
Analysis of Variance | 2 | 2010 | 6367 | 0.020 |
Why?
|
Time Factors | 1 | 2012 | 40063 | 0.020 |
Why?
|
Pregnancy Outcome | 1 | 2021 | 2796 | 0.020 |
Why?
|
Drugs, Generic | 1 | 2015 | 422 | 0.020 |
Why?
|
Cholesterol, LDL | 2 | 2010 | 2355 | 0.020 |
Why?
|
Diabetic Retinopathy | 1 | 2019 | 1210 | 0.020 |
Why?
|
Models, Biological | 1 | 2006 | 9582 | 0.020 |
Why?
|
Internship and Residency | 1 | 2010 | 5787 | 0.020 |
Why?
|
United States | 2 | 2015 | 69867 | 0.020 |
Why?
|
Leukocytes, Mononuclear | 1 | 2015 | 1836 | 0.020 |
Why?
|
Propensity Score | 1 | 2015 | 1781 | 0.020 |
Why?
|
Societies, Medical | 2 | 2012 | 3741 | 0.020 |
Why?
|
Toll-Like Receptor 1 | 1 | 2008 | 48 | 0.020 |
Why?
|
Lipopeptides | 1 | 2008 | 75 | 0.020 |
Why?
|
Fatty Acids, Nonesterified | 1 | 2009 | 402 | 0.020 |
Why?
|
Surgical Wound Infection | 1 | 2016 | 1540 | 0.020 |
Why?
|
Interleukin-8 | 1 | 2010 | 690 | 0.020 |
Why?
|
Coculture Techniques | 1 | 2010 | 1341 | 0.020 |
Why?
|
Antigens, Differentiation, Myelomonocytic | 1 | 2008 | 294 | 0.020 |
Why?
|
Chromatin Immunoprecipitation | 1 | 2009 | 893 | 0.020 |
Why?
|
Transcription Factor RelA | 1 | 2008 | 275 | 0.020 |
Why?
|
Fluorodeoxyglucose F18 | 1 | 2014 | 2017 | 0.020 |
Why?
|
Toll-Like Receptor 2 | 1 | 2008 | 354 | 0.020 |
Why?
|
Drug Prescriptions | 1 | 2015 | 1637 | 0.020 |
Why?
|
Microscopy, Electron, Scanning | 1 | 2007 | 964 | 0.020 |
Why?
|
T-Lymphocytes, Helper-Inducer | 1 | 2010 | 986 | 0.020 |
Why?
|
Health Care Surveys | 1 | 2012 | 2453 | 0.020 |
Why?
|
Protein Kinase Inhibitors | 1 | 2021 | 5529 | 0.020 |
Why?
|
Renal Insufficiency, Chronic | 1 | 2019 | 2208 | 0.020 |
Why?
|
Randomized Controlled Trials as Topic | 1 | 2021 | 9960 | 0.020 |
Why?
|
Risk | 1 | 2017 | 9685 | 0.020 |
Why?
|
Signal Transduction | 1 | 2008 | 23404 | 0.020 |
Why?
|
Interleukin-17 | 1 | 2010 | 900 | 0.020 |
Why?
|
Interleukin-10 | 1 | 2010 | 1200 | 0.020 |
Why?
|
Toll-Like Receptor 4 | 1 | 2008 | 567 | 0.020 |
Why?
|
Radiopharmaceuticals | 1 | 2014 | 2662 | 0.020 |
Why?
|
Boston | 1 | 2017 | 9311 | 0.010 |
Why?
|
Decision Making | 1 | 2018 | 3888 | 0.010 |
Why?
|
Nitroglycerin | 1 | 2005 | 325 | 0.010 |
Why?
|
Pulsatile Flow | 1 | 2005 | 332 | 0.010 |
Why?
|
Statistics, Nonparametric | 1 | 2009 | 2886 | 0.010 |
Why?
|
Mass Screening | 1 | 2019 | 5252 | 0.010 |
Why?
|
Statistics as Topic | 1 | 2009 | 2374 | 0.010 |
Why?
|
RNA, Messenger | 2 | 2008 | 13036 | 0.010 |
Why?
|
Severity of Illness Index | 2 | 2011 | 15538 | 0.010 |
Why?
|
Thoracic Surgery | 1 | 2009 | 719 | 0.010 |
Why?
|
Interferon-gamma | 1 | 2010 | 3203 | 0.010 |
Why?
|
Circadian Rhythm | 1 | 2012 | 2624 | 0.010 |
Why?
|
Infant, Newborn | 1 | 2021 | 25618 | 0.010 |
Why?
|
Electronic Health Records | 1 | 2017 | 4463 | 0.010 |
Why?
|
Databases, Factual | 1 | 2015 | 7730 | 0.010 |
Why?
|
Linear Models | 1 | 2009 | 5953 | 0.010 |
Why?
|
Pregnancy | 1 | 2021 | 29142 | 0.010 |
Why?
|
Hypertension | 1 | 2019 | 8480 | 0.010 |
Why?
|
Child | 2 | 2013 | 77679 | 0.010 |
Why?
|
Polymerase Chain Reaction | 1 | 2008 | 6172 | 0.010 |
Why?
|
Positron-Emission Tomography | 1 | 2014 | 6274 | 0.010 |
Why?
|
Interleukin-6 | 1 | 2008 | 3201 | 0.010 |
Why?
|
Antigens, CD | 1 | 2008 | 4026 | 0.010 |
Why?
|
Child, Preschool | 1 | 2000 | 40992 | 0.010 |
Why?
|
Gastric Bypass | 1 | 2005 | 812 | 0.010 |
Why?
|
Disease Progression | 1 | 2012 | 13280 | 0.010 |
Why?
|
Biopsy | 1 | 2008 | 6757 | 0.010 |
Why?
|
Survival Analysis | 1 | 2009 | 10250 | 0.010 |
Why?
|
Peptides | 1 | 2008 | 4407 | 0.010 |
Why?
|
Heart Failure | 1 | 2019 | 10905 | 0.010 |
Why?
|
Ultrasonography | 1 | 2008 | 5982 | 0.010 |
Why?
|
Coronary Angiography | 1 | 2006 | 4578 | 0.010 |
Why?
|
Sensitivity and Specificity | 1 | 2009 | 14726 | 0.010 |
Why?
|
Heart Ventricles | 1 | 2006 | 3820 | 0.010 |
Why?
|
Cell Differentiation | 1 | 2010 | 11478 | 0.010 |
Why?
|
Mice | 2 | 2013 | 81178 | 0.010 |
Why?
|
Echocardiography | 1 | 2006 | 5103 | 0.010 |
Why?
|
Tomography, X-Ray Computed | 1 | 2014 | 20123 | 0.010 |
Why?
|
Phenotype | 1 | 2008 | 16365 | 0.010 |
Why?
|
Cross-Sectional Studies | 1 | 2010 | 25043 | 0.010 |
Why?
|
Animals | 2 | 2013 | 168788 | 0.000 |
Why?
|
Magnetic Resonance Imaging | 1 | 2006 | 35423 | 0.000 |
Why?
|